Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · Real-Time Price · USD
2.145
+0.055 (2.63%)
Jul 9, 2025, 9:56 AM - Market open
Myomo Market Cap
Myomo has a market cap or net worth of $77.17 million as of July 9, 2025. Its market cap has decreased by -14.72% in one year.
Market Cap
77.17M
Enterprise Value
61.94M
1-Year Change
-14.72%
Ranking
Category
Stock Price
$2.15
Market Cap Chart
Since June 30, 2017, Myomo's market cap has increased from $66.00M to $77.17M, an increase of 16.93%. That is a compound annual growth rate of 1.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2025 | 75.20M | -61.40% |
| Dec 31, 2024 | 194.80M | 46.69% |
| Dec 29, 2023 | 132.80M | 3,588.89% |
| Dec 30, 2022 | 3.60M | -92.34% |
| Dec 31, 2021 | 47.00M | 52.60% |
| Dec 31, 2020 | 30.80M | 492.31% |
| Dec 31, 2019 | 5.20M | -70.95% |
| Dec 31, 2018 | 17.90M | -21.83% |
| Dec 29, 2017 | 22.90M | -65.30% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.13B |
| Johnson & Johnson | 374.84B |
| AbbVie | 335.21B |
| Novo Nordisk | 313.36B |
| UnitedHealth Group | 279.13B |
| Novartis AG | 240.15B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 217.48B |